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Objectives. The objective of this study was to develop a technique for detecting cortical bone dimensional changes in
patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Study Design. Subjects with BRONJ who had cone-beam computed tomography imaging were selected, with age- and
gender-matched controls. Mandibular cortical bone measurements to detect bisphosphonate-related cortical bone changes
were made inferior to mental foramen, in 3 different ways: within a fixed sized rectangle, in a rectangle varying with the
cortical height, and a ratio between area and height.
Results. Twelve BRONJ cases and 66 controls were evaluated. The cortical bone measurements were significantly higher in
cases than controls for all 3 techniques. The bone measurements were strongly associated with BRONJ case status (odds ratio
3.36-7.84). The inter-rater reliability coefficients were high for all techniques (0.71-0.90).
Conclusions. Mandibular cortical bone measurement is a potentially useful tool in the detection of bone dimensional changes
caused by bisphosphonates. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:695-703)Long-term administration of bisphosphonates (BPs) af-
fects bone quality and metabolism following accumu-
lation in bone.1 Since the first cases of bisphosphonate-
related osteonecrosis of the jaw (BRONJ) were
published in 2003,2 there has been a search for factors
that can predict the onset of the condition. Oral and
intravenous BPs reduce bone resorption, increase min-
eral content of bone, and alter bony architecture.3-6
Previous studies have demonstrated these changes both
radiographically and following histologic analy-
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doi:10.1016/j.oooo.2011.11.011sis.1,3,7-10 The BP-related jaw changes may present
radiological features, such as thickening of lamina dura
and cortical borders, diffuse sclerosis, and narrowing of
the mandibular canal3,11; however, oral radiographs of
patients taking BPs do not consistently show radio-
graphic changes to the jaws.11,12 The challenge is to
find imaging tools that could improve the detection of
changes in the bone associated with BP use.
Various skeletal radiographic features associated
with BRONJ in conventional periapical and panoramic
radiographs, computed tomography, magnetic reso-
nance imaging, and nuclear bone scanning have been
described.3,8-11 There has also been a search for BP-
related quantitative methods for the evaluation of ra-
diographic images, to avoid observer subjectivity in
interpretation. Factors thought to be important include
trabecular and cortical structure, and bone mineraliza-
tion.4 Consequently, measurable bone data have been
reported in subjects taking BPs through many tech-
niques, including bone density, architecture, and corti-
cal bone thickness.1,4,7,13 Trabecular microarchitecture
of postmenopausal women has been evaluated with
noninvasive techniques, such as high-resolution mag-
netic resonance images showing less deterioration of
the bone 1 year after initiation of oral BP therapy.4 A
decrease in bone turnover and a trend for an increase in
the bone wall thickness has been detected by histomor-
phometry in subjects taking BPs.1 Alterations in the
cortical structure of the second metacarpal have been
detected in digital x-ray radiogrammetry of postmeno-
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width may be measured on dental panoramic radio-
graphs, and it has been suggested as a screening tool for
referring patients for bone densitometry for osteoporo-
sis investigation.14,15
Inhibition of the intracortical bone remodeling in the
mandible of mice taking BPs has been reported.16 Thus,
imaging evaluation of the mandibular cortical bone
could be a biologically plausible way to detect BP bone
alterations. Computed tomography can assess both cor-
tical and trabecular bone characteristics. Cone-beam
computed tomography (CBCT) can provide 3-dimen-
sional information, while using lower doses and costing
less than conventional CT. The CBCT images have
been studied as a tool for the measurement of trabecular
bone in patients with BRONJ.13 Therefore, cortical
bone measurements on CBCT of the jaws might also
help to understand bone changes in patients with
BRONJ.
There is no standard in quantifying dimensional
changes of mandibular cortical bone. We explored sev-
eral different approaches to take into consideration
possible changes in length, area, and volume. These led
to the 3 techniques developed in this study.
This article reports a matched case-control study in
which mandibular cortical bone was measured on
CBCT images of subjects with BRONJ and controls.
The aim of the study was to explore the usefulness of 3
techniques for detecting mandibular cortical bone di-
mensional changes caused by BP.
MATERIAL AND METHODS
All subjects with clinical features of BRONJ that had
been referred to the Division of Oral Radiology, De-
partment of Oral Medicine, of the University of Wash-
ington for CBCT imaging were selected from the ar-
chives. The goal was to have 5 gender- and age-matched
controls selected for each BRONJ case, from the same
archives. The use of 5 controls per case provides a
substantial increase in statistical power. Images were
excluded if the predetermined selected area for exam-
ination was not covered by the examination. The cases
and controls were masked for the evaluation by at least
2 examiners, who were trained by one of the investi-
gators. Each examiner independently carried out image
procurement, manipulation, and subsequent measuring.
All CBCT procedures were standardized, obtained
with CBCT system CB MercuRay equipment (Hitachi
Medical Corporation, Tokyo, Japan), and saved into
CBWorks software (version 3.0; Cybermed, Seoul, Ko-
rea). Images were realigned in a way that the inferior
border, inferior to the mental foramen, was horizontal
in all views (axial, sagittal, and coronal). The cortical
bone was highlighted through the software tools and themandibular cortical bone measurements were obtained
using the mental foramen as an anatomical marker, on
the right side. To find a method with high consistency,
the measurements were obtained with 3 different tech-
niques, and analyzed to detect differences attributable
to BP-related cortical bone dimensional changes. Fac-
tors considered in this analysis were (1) the odds ratio
(OR) for detecting associations between BRONJ and
bone measures; (2) the reliability of the measures; and
(3) biological plausibility.
Technique 1
The mandibular cortical bone volume was calculated in
a fixed-size volume of 250 mm3 (10 mm  5 mm  5
mm) (Figure 1). Using the lined grid and the scale bar,
a 10  5-mm rectangle was positioned on the lower
border of the mandible, tangentially to the inferior
border, inferior to the mental foramen, on the coronal
plane. On the axial plane, a 10  5-mm rectangle was
positioned using the mental foramen as a guide. The
volume of cortical bone contained in the defined rect-
angle was automatically calculated in cubic millimeter
(mm3) by the software (Figure 2, A).
Technique 2
The mandibular cortical bone measurements were ob-
tained in a rectangle that had a fixed width, but varied
in height relative to the lower mandibular cortical
height. An area 15 5 mm was selected and positioned
using the mental foramen as a guide, on the axial plane.
On the coronal plane, the lower border of the rectangle
was positioned tangentially to the mandibular inferior
border, inferior to the mental foramen, and the upper
border of the rectangle was positioned tangentially to
the internal border of the cortical bone. Both the vol-
ume (located on all planes) and the area (on the coronal
plane) of the cortical bone contained in the defined
rectangle were automatically calculated by the soft-
ware, in cubic millimeters and square millimeters, re-
spectively. The length tool was used to calculate the
height of the cortical bone in millimeters, in the same
area, on the coronal plane (Figure 2, B).
Technique 3
The total mandibular cortical bone area was determined
on the coronal plane, in the region of the mental fora-
men between the roots of the teeth. The entire mandib-
ular bony section on the coronal plane was highlighted
by the software, and the area of the cortical bone was
automatically calculated by the software, in square mil-
limeters. The height of the whole mandible was calcu-
lated with the length tool, from the lower border of the
mandible to the highest point of the alveolar crest bone,
in millimeters. The ratio between the area and the
2, 3-di
OOOO ORIGINAL ARTICLE
Volume 113, Number 5 Torres et al. 697height was used as the measurement. The software does
not identify differences among different calcified struc-
tures. Thus, we eliminated from the study the images in
which a root of a tooth was included, because there was
not enough space between the 2 neighboring roots to
avoid inclusion of parts of the root in the image (Figure
2, C).
Fisher and 1-way analysis of variance (ANOVA)
tests were used to analyze differences between groups,
for categorical and measurable variables, respectively.
Fig. 1. Steps for acquisition of measurements for technique 1.
plane—a 10  5-mm rectangle (black arrow) positioned usi
rectangle (black arrow) positioned with the inferior border t
foramen; A3, sagittal plane—a 5  5-mm square (arrowhea
After selection of the region of interest, the volume of the co
software: B1, coronal plane—highlighted selected region; BTo establish the OR for the cortical bone measure-ments, the results were dichotomized in low and high
cortical bone volume, area and height, respectively,
using the 75th percentile in the control group as the
cutoff point for each measure. The inter-rater reliability
was determined by bivariate Pearson correlation. The
significance level was set at .05. SPSS 10.0 software
version 10 (SPSS Inc., IBM Company Headquarters,
Chicago, IL) was used for storing and analyzing data.
The VassarStats Web site for Statistical Computation
(Richard Lowry, Poughkeepsie, NY) was used to cal-
lanar reconstruction (MPR) showing the following: A1, axial
mental foramen as a guide; A2, coronal plane—same-sized
ial to the lower border of the cortical, inferior to the mental
tomatically positioned on the lower border of the mandible.
one contained in the defined rectangle was calculated by the
mensional image of the selected region.Multip
ng the
angent
d) is au
rtical bculate OR and its 95% confidence interval (CI).17
al area
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view board and need for informal consent was waived.
The procedures followed were in accordance with the
ethical standards of the responsible committee on hu-
man experimentation and with the Helsinki Declaration
of 1975, as revised in 1983.
RESULTS
There were 12 BRONJ cases and 66 controls prese-
lected for the study. The demographic and radio-
graphic characteristics of the BRONJ cases are
shown in Table I. Twenty subjects were excluded
because the area of the cortical bone inferior to the
mental foramen was not available on the CBCT
image. From the 58 subjects selected for the man-
dibular cortical measurements, there were 7 women
and 3 men in the BRONJ group, and 34 women and
14 men in the control group. The mean ages were
63.75 (SD 13.89) for the patients with BRONJ and
62.61 (SD 13.54) for the controls. There was no
significant difference in age (P  .79) or gender
(P  .61) between the 2 groups. From the patients
presenting BRONJ, 9 had the exposed bone in the
mandible and 1 in the maxilla. The reasons for hav-
ing the CBCT procedure in controls were implant
placement (32), temporomandibular joint disorders
(10), pain or numbness (2), cyst (2), tooth resorption
(1), or apicoectomy (1). For technique 3, 7 more
subjects were excluded because the bone space be-
tween roots was not large enough to allow measure-
ment. Table II shows the results obtained for the
Fig. 2. Cortical bone measurements taken by 3 different tec
rectangle; B, technique 2, cortical bone volume, area, and heig
C, technique 3, a ratio between the whole mandibular corticcortical bone measurements and the number of stud-ied subjects for the 3 techniques evaluated in the
study.
The mean cortical bone height was significantly
higher for subjects with BRONJ than for controls in all
techniques (Figure 3). The cutoff points obtained for
the different methods were as follows: technique 1,
high cortical bone volume greater than 161.31 mm3;
technique 2, high cortical bone volume greater than
162.55 mm3, high cortical bone area greater than
31.88 mm2, high cortical bone height greater than 4.7
mm; and technique 3, high ratio cortical bone area/
height greater than 6.99 mm. The odds of being a
BRONJ case versus being a control were higher for
an individual with higher cortical plate volume, area,
thickness, and ratio of the whole mandibular cortical
bone area/height.
Technique 1 showed the highest OR to detect cortical
bone dimensional changes, but in many cases, the fixed
vertical dimension of the rectangle did not include the
total height of the cortex. In technique 2, the cortical
bone height presented a good OR and a good inter-rater
coefficient. Furthermore, it represented a more biolog-
ically plausible way of measuring, as it included the
total height of the lower mandibular cortex.
The inter-rater reliability was tested for 31 of the
subjects by 2 of the investigators (S.R.T. and E.C.A.S.),
for technique 1. For technique 2, the inter-rater reliabil-
ity was tested for 33 of the subjects by 3 of the inves-
tigators (S.R.T., S.P.D., and K.C.H.), and varied from
0.87 to 0.92 for the cortical bone volume; 0.66 to 0.83
for the area; and 0.87 to 0.94 for the height. The mean
s. A, Technique 1, cortical bone volume within a fixed size
hin a rectangle that varies with the mandibular cortical height;
and the height was obtained.hnique
ht, witof the inter-rater results for technique 2 are presented in
one-bea
nd mea
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technique 3 because of the high number of subjects
excluded.
To explore the association between the bone mea-
sures and the demographic factors (age and gender), we
also evaluated the control group separately to check for
differences in the cortical bone measurements. There
was no statistically significant difference in cortical
bone measurements for gender (Fisher, P  .05) in any
Table I. Characteristics of the CBCT images of the p
Case no. Gender Age BRONJ site
1 F 63 Right and left maxilla Scle
b
fi
2 F 67 Left mandible Ero
li
3 F 68 Right mandible Scle
e
4 F 67 Right and left mandible Den
a
5 F 43 Left mandible Eno
6 F 49 Left mandible Eno
7 M 59 Left mandible Ero
8 M 50 Left mandible Ext
m
9 F 82 Right mandible Mar
10 F 78 Right and left mandible Mar
11 F 47 Left maxilla Mas
th
12 M 82 Left mandible Wid
s
BRONJ, bisphosphonate related osteonecrosis of the jaws; CBCT, c
Table II. Values of cortical bone measurements obtain
study
No. of
cases
included
(excluded)
No. of cases
initially studied
by groups
(excluded)
BRONJ ca
Mean 
BRONJ
n  12
Controls
n  66
Technique 1
Cortical bone volume (mm3) 58 (20) 10 (2) 48 (18) 166.18  34
Technique 2
Cortical bone volume (mm3) 58 (20) 10 (2) 48 (18) 268.43  18
Cortical bone area (mm2) 58 (20) 10 (2) 48 (18) 49.54  31
Cortical bone height (mm) 58 (20) 10 (2) 48 (18) 6.05  2.
Technique 3
Ratio cortical bone area/height 51 (27) 9 (3) 42 (24) 7.47  1.
BRONJ, bisphosphonates-related osteonecrosis of the jaws; CI, confi
*One-way analysis of variance.
†Fisher exact test.
‡Pearson correlation, values between 2 examiners for technique 1, aof the 3 techniques. There was also no correlation ofhigh and low cortical bone measurements with age
(1-way ANOVA, P .05), even when women and men
were analyzed separately, in the 3 techniques.
DISCUSSION
The present study evaluated the cortical mandibular
bone in CBCT images of patients with BRONJ and
controls. Three different techniques were tested ini-
tially for their reproducibility and ability to demonstrate
ted cases with BRONJ
Bone characteristics in BRONJ site
ony pattern, with area of radiolucencies and sequestra. Borders of
maxillary sinuses are also sclerotic and thick, and sinuses are
th soft tissues.
d bony specula on the lingual cortical bone; widened periodontal
space
ith osteolytic changes and a large sequestrum in the center;
f the lingual cortical bone
in teeth-bearing area extending to the ramus with small osteolytic
nhealed sockets on molar area; thickening of lamina dura
lingual cortex
dense bony structure; periosteal reaction; nonhealed sockets on
ea; impacted teeth
erosis; osteolysis; sequestrum
erosis; sequestrum
lerosis of alveolar process, widened periodontal ligament, and
rounding lamina dura
osteosclerotic and osteolytic changes; periosteal reaction;
m
m computed tomography; F, female; M, male.
m the 78 subjects for the 3 techniques evaluated in the
Controls
Mean  SD
P
value*
High/normal
cortical bone
Odds ratio (CI)
P value†
Inter-rater
reliability‡
BRONJ
n (%)
Controls
n (%)
41.65  24.60 .01 7/3 11/37 7.84 (1.73–35.55) 0.85
.006
35.32  38.52 .01 5/5 11/37 3.36 (0.82–13.78) 0.89
.09
27.69  7.71 .01 5/5 11/37 3.36 (0.82–13.78) 0.71
.09
4.22  0.80 .01 6/4 11/37 5.04 (1.20–21.14) 0.90
.02
6.17  1.23 .01 5/4 10/32 4.00 (0.89–17.82) —
.07
interval.
n values between the 3 examiners for technique 2.reselec
rotic b
ilateral
lled wi
sion an
gament
rosis w
rosion o
se bone
reas; no
stosis
stosis
sion on
remely
olar ar
ked scl
ked scl
sive sc
ick sur
espread
equestrued fro
ses
SD
.67 1
9.54 1
.75
18
90
dencedifferences in the amounts of cortical bone along the
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700 Torres et al. May 2012Fig. 3. Box-plot graphs of the mandibular cortical bone measurements from cases with BRONJ and controls. A, Cortical bone
volume obtained by technique 1; B, cortical bone volume by technique 2; C, cortical bone area by technique 2; D, cortical bone
height by technique 2; E, the ratio between the entire mandibular cortical area and the height obtained by technique 3. The blank
circles in the graphs represent outliers, which are extreme values that deviate from the rest of the sample.
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Volume 113, Number 5 Torres et al. 701inferior borders of the mandibles. All 3 techniques were
able to show BP-related mandibular cortical bone di-
mensional changes. The thickness of the inferior man-
dibular cortex in the region of the mental foramen
seems to be the most promising measurement, as it
showed the best reliability, high OR, and also biologi-
cal plausibility, as it includes the whole mandibular
cortex in the analysis. In the studied population, pa-
tients with BRONJ showed significantly higher man-
dibular inferior cortical bone measurements when com-
pared with controls.
Several experimental and clinical studies have shown
changes related to BP therapy in the mandibular cor-
tex.6,7,16,18-22 Human studies based on histomorphom-
etry and imaging (x-ray radiogrammetry) methods have
reported larger cortical thickness in patients under BP
therapy.7,19 Some case series and case reports have
pointed to the cortical alterations in the images of the
mandible of patients undertaking BP.10,23,24
The mineralized skeleton is defined externally by its
periosteal surface and internally by the endosteal sur-
face (endocortical, intracortical, and trabecular compo-
nents).25 The endocortical component is the compact
bone on the inside surface of the cortex, facing the
marrow compartment, and the intracortical component
is the bone within the cortex.25-27 Most of the recent
studies on the pathogenesis of BRONJ point to the
effect of BPs on cortical bone remodeling.18,28 Model-
ing is responsible for changes in bone shape and mass
during growth, whereas the main effect of remodeling
is to renew existing bone.27 In older humans, bone
elongation ceases, periosteal expansion continues, and
bone remodeling remains a dominant metabolic pro-
cess.29 The type of remodeling that occurs within cor-
tical bone of humans is intracortical (osteonal).5,20,30
Animal studies have shown that BP suppresses the
endocortical and the intracortical remodeling in the
mandible.6,16,18,20,21
It is unlikely that BP has an effect on bone model-
ing.6,20 Although the periosteal bone surface can un-
dergo remodeling, most activity on this bone surface is
modeling.6,20 In this way, BP has a positive effect on
cortical bone by allowing customary periosteal growth,
while reducing the rate of endocortical bone remodel-
ing and slowing bone loss from the endocortical sur-
face.31 For CT-imaging, case-series studies, it was
found that there is periosteal bone proliferation on the
mandibles of patients with BRONJ.10,23,24 One consid-
eration is that the periosteal proliferation described by
these authors may also be a response to other factors,
such as aging or sex steroids.32 In the CBCT images of
the present study, we observed 2 cases with periosteal
reaction, although it was hard to distinguish between
cortical and periosteal bone on our CBCT images,especially after the mineralized structures were high-
lighted with the software used.
To detect dimensional changes in cortical bone, 3
techniques were investigated in this study. For the first
technique, the limitation was that in many images, the
endocortical border, which is one of the targets of the
BP action,33 was not included in the measurement. This
technique also had the limitation of the rectangle width;
so many subjects with large mandibular width had part
of the cortex excluded by the “box.” Even with these
limitations, the odds and the reproducibility of the
method were good. With technique 2, the problem of
the mandible width variation was corrected, in a way
that all mandibular widths would fit inside a larger
rectangle, and only the height of the cortical bone
varied. The measurements of volume, area, and height
were obtained with good OR and reproducibility. This
presented the most biologically plausible method be-
cause it included the endocortical and the periosteal
borders in the analysis. Similar to the mandibular cor-
tical thickness used to detect osteoporosis signs on
panoramic radiographs,14,15 cortical bone height on
CBCT images might be a tool to detect cortical bone
dimensional changes caused by BP. Technique 3 was
developed so that it could possibly correct for the
variations in mandibular height and width that occur in
individuals. Thus, we used a ratio of the whole man-
dibular bone area and height. There were many images
that had to be excluded from the evaluation, because
there was not enough bone space between the neigh-
boring roots to be evaluated. The software that was
used does not recognize the difference between calci-
fied structures and added the root surface area to the
area of cortical bone; moreover, the calcified areas of
cancellous bone were also included in the calculation
by the software.
A difference in the cortical bone thickness might
have been expected between individuals of different
gender and age in the normal population. To verify this
difference, the 48 individuals of the control group were
evaluated and no difference was found in the cortical
bone height for gender or for age. Because controls
were age and gender matched to cases of BRONJ, the
studied controls might not have represented the general
population. Further studies are needed to investigate
cortical bone measurements in larger healthy popula-
tions, controlling for gender and age. An additional
investigation would be studying the mandibular cortex
controlling for the influence of mechanical loading and
the mandibular strength. The present study was not
designed for that type of evaluation.
One limitation of the study was that the data on the
type, dose, route, and duration of BP therapy were not
available. The risk for BRONJ has been related as
ORAL AND MAXILLOFACIAL RADIOLOGY OOOO
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there was no information on the medical history of
controls. As this part of the study was waived of con-
sent, we could not collect data from the clinical files to
obtain this information. For the same reason, we do not
know if cortical bone differs in subjects under BP
therapy who present or do not present BRONJ, and this
will be the subject of our next study.
This retrospective pilot study was useful to guide the
selection of the proper technique for future studies to
analyze cortical bone dimensional changes related to
BP. Radiologists who work with CBCT should be able
to easily reproduce this methodology, as the reliability
rate was high, even when performed by nonradiologist
examiners. Clinicians may benefit from this measure-
ment to detect subjects more affected by BP therapy.
Future studies should focus on the prospective evalua-
tion of subjects on different BP therapies, and the
variations of cortical bone in the healthy population.
A potentially important finding of this study is that
BP changes in bone structure could be detected even in
areas of the mandible not compromised by the bone
exposure of BRONJ. Thus, CBCT examinations of
subjects taking BP might be able to show early bone
alterations associated with treatment.
This result is promising, as it suggests that the di-
mensional changes of the cortical bone might predict
BRONJ in individuals on BP therapy. To support this
possibility, longitudinal studies should be performed in
individuals on BP therapy. Longitudinal studies with
this type of evaluation would also confirm the time-
dependent effect of BP on the bone reported in preclin-
ical studies.6,18
In conclusion, the evaluation of the mandibular cor-
tical bone in the mental foramen area seems to be a
useful tool in the detection of cortical bone dimensional
changes caused by BPs. Technique 2 seems to be the
most promising measurement for its biological plausi-
bility, as it includes the inner and outer mandibular
cortex in the analysis. This test may give an indication
of possible surgical complications in patients undergo-
ing BP therapy. Future multicenter studies are sug-
gested, to assess larger samples and to confirm these
results.
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